Benzinga | Mar 25, 2021 04:06PM EDT

ADMA Biologics Q4 EPS $(0.20) Misses $(0.16) Estimate, Sales $13.96M Beat $12.91M Estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 11.11 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $13.96 million which beat the analyst consensus estimate of $12.91 million by 8.10 percent. This is a 15.94 percent increase over sales of $12.04 million the same period last year.